Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000343573 | SCV000329994 | pathogenic | not provided | 2016-12-13 | criteria provided, single submitter | clinical testing | The W43R pathogenic variant in the XRCC4 gene has been reported previously in the homozygous state in at least two individuals with microcephalic primordial dwarfism (Shaheen et al., 2014; Murray et al., 2015). Functional studies demonstrate that this variant impairs XRCC4 function and results in greatly reduced protein levels as compared to wild type (Murray et al., 2015; Guo et al., 2015). The W43R variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a non-conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret W43R as a pathogenic variant. |
Pathology and Clinical Laboratory Medicine, |
RCV000190521 | SCV001438862 | likely pathogenic | Short stature, microcephaly, and endocrine dysfunction | criteria provided, single submitter | clinical testing | ||
Institute of Medical Genetics and Applied Genomics, |
RCV000343573 | SCV001448078 | pathogenic | not provided | 2020-10-23 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000115044 | SCV000108409 | pathogenic | Ateleiotic dwarfism | no assertion criteria provided | research | ||
OMIM | RCV000190521 | SCV000245407 | pathogenic | Short stature, microcephaly, and endocrine dysfunction | 2015-07-23 | no assertion criteria provided | literature only | |
Prevention |
RCV004748579 | SCV005342954 | pathogenic | XRCC4-related disorder | 2024-07-23 | no assertion criteria provided | clinical testing | The XRCC4 c.127T>C variant is predicted to result in the amino acid substitution p.Trp43Arg. This variant has been reported in the homozygous state in individuals with short stature and microcephaly (Shaheen et al. 2014. PubMed ID: 24389050; Shaheen et al. 2018. PubMed ID: 30214071; Asa et al. 2021. PubMed ID: 33842963). Functional studies showed that this variant impacts protein functions (Murray et al. 2015. PubMed ID: 25728776; Asa et al. 2021. PubMed ID: 33842963). This variant is reported in 0.013% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as pathogenic |